Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

GALE Antikörper (N-Term)

Der Kaninchen Polyklonal Anti-GALE Antikörper wurde für WB validiert. Er ist geeignet, GALE in Proben von Human, Maus, Ratte, Hund, Rind (Kuh), Schwein, Kaninchen und Meerschweinchen zu detektieren.
Produktnummer ABIN2785690
534,11 €
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 6 bis 8 Werktagen

Kurzübersicht für GALE Antikörper (N-Term) (ABIN2785690)

Target

Alle GALE Antikörper anzeigen
GALE (UDP-Galactose-4-Epimerase (GALE))

Reaktivität

  • 37
  • 18
  • 5
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Human, Maus, Ratte, Hund, Rind (Kuh), Schwein, Kaninchen, Meerschweinchen

Wirt

  • 46
  • 6
Kaninchen

Klonalität

  • 48
  • 4
Polyklonal

Konjugat

  • 23
  • 4
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser GALE Antikörper ist unkonjugiert

Applikation

  • 41
  • 16
  • 13
  • 13
  • 5
  • 5
  • 5
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB)
  • Bindungsspezifität

    • 15
    • 9
    • 7
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    N-Term

    Sequenz

    AEKVLVTGGA GYIGSHTVLE LLEAGYLPVV IDNFHNAFRG GGSLPESLRR

    Homologie

    Cow: 93%, Dog: 86%, Guinea Pig: 86%, Human: 100%, Mouse: 91%, Pig: 91%, Rabbit: 92%, Rat: 91%

    Produktmerkmale

    This is a rabbit polyclonal antibody against GALE. It was validated on Western Blot using a cell lysate as a positive control.

    Aufreinigung

    Affinity Purified

    Immunogen

    The immunogen is a synthetic peptide directed towards the N terminal region of human GALE
  • Applikationshinweise

    Optimal working dilutions should be determined experimentally by the investigator.

    Kommentare

    Antigen size: 348 AA

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    Lot specific

    Buffer

    Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    Avoid repeated freeze-thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
  • Target

    GALE (UDP-Galactose-4-Epimerase (GALE))

    Andere Bezeichnung

    GALE

    Hintergrund

    GALE is an UDP-galactose-4-epimerase which catalyzes two distinct but analogous reactions: the epimerization of UDP-glucose to UDP-galactose, and the epimerization of UDP-N-acetylglucosamine to UDP-N-acetylgalactosamine. The bifunctional nature of the enzyme has the important metabolic consequence that mutant cells (or individuals) are dependent not only on exogenous galactose, but also on exogenous N-acetylgalactosamine as a necessary precursor for the synthesis of glycoproteins and glycolipids. Mutations in this gene result in epimerase-deficiency galactosemia, also referred to as galactosemia type 3, a disease characterized by liver damage, early-onset cataracts, deafness and mental retardation, with symptoms ranging from mild ('peripheral' form) to severe ('generalized' form). This gene encodes UDP-galactose-4-epimerase which catalyzes two distinct but analogous reactions: the epimerization of UDP-glucose to UDP-galactose, and the epimerization of UDP-N-acetylglucosamine to UDP-N-acetylgalactosamine. The bifunctional nature of the enzyme has the important metabolic consequence that mutant cells (or individuals) are dependent not only on exogenous galactose, but also on exogenous N-acetylgalactosamine as a necessary precursor for the synthesis of glycoproteins and glycolipids. Mutations in this gene result in epimerase-deficiency galactosemia, also referred to as galactosemia type 3, a disease characterized by liver damage, early-onset cataracts, deafness and mental retardation, with symptoms ranging from mild ('peripheral' form) to severe ('generalized' form). Multiple alternatively spliced transcripts encoding the same protein have been identified.
    Alias Symbols: SDR1E1
    Protein Interaction Partner: GALE, SUMO2, UBC, BAG3, FN1, APP,
    Protein Size: 348

    Molekulargewicht

    38 kDa

    Gen-ID

    2582

    NCBI Accession

    NM_001008216, NP_001008217

    UniProt

    Q14376

    Pathways

    Response to Water Deprivation, Cellular Glucan Metabolic Process
Sie sind hier:
Chat with us!